Company: APXIF
Filing Date: 2025-06-13
Form Type: F-4/A
Source: 0001213900-25-054324
Chunk: 701

Company: APx Acquisition Corp. I
Filing Date: 2025-06-13
Form: F-4/A
Chunk 701
---
M is responsible for allocating resources and assessing performance of the business. The Executive Team measures the performance of the Group’s business by its “Gross Profit or Loss” as per the statement of operations.

F-157

Notes to Combined Financial Statements (Amounts in US Dollars, except otherwise indicated) 21.Segment information (cont.) Business segment information for the years ended June 30, 2024 and 2023 is as follows:

| Year ended June 30, 2024  |     |     Heritas 
 Diagnostics |   |     |   Rewell |   |     | Total as per the 
     statement of 
       operations |   |
|:--------------------------|:----|------------:|:--|:----|---------:|:--|:----|-----------------:|:--|
| Revenues                  |     |   1,702,559 |   |     |  116,811 |   |     |        1,819,370 |   |
| Cost of revenues(*)       |     |  (1,631,757 | ) |     | (242,981 | ) |     |       (1,874,738 | ) |
| Profit/(Loss) per segment |     |      70,802 |   |     | (126,170 | ) |     |          (55,368 | ) |

| Year ended June 30, 2023  |     |     Heritas 
 Diagnostics |   |     |   Rewell |   |     | Total as per the 
     statement of 
       operations |   |
|:--------------------------|:----|------------:|:--|:----|---------:|:--|:----|-----------------:|:--|
| Revenues                  |     |   1,824,664 |   |     |   55,275 |   |     |        1,879,939 |   |
| Cost of revenues(*)       |     |  (1,768,503 | ) |     | (151,940 | ) |     |       (1,920,443 | ) |
| Profit/(Loss) per segment |     |      56,159 |   |     |  (96,663 | ) |     |          (40,504 | ) |

There are no transactions between segments for any of the years presented. The revenue breakdown per segment is included in Note 16. For details of concentration